case stringlengths 641 3.97k | reasoning stringlengths 324 937 | answer stringlengths 1.44k 6k | category stringclasses 4
values |
|---|---|---|---|
A 16-year-old Hispanic female presents with a 6-month history of progressive right nasal obstruction, epistaxis, and right facial swelling. Initial examination revealed a mass obstructing the right nasal cavity. Biopsy confirmed poorly differentiated squamous cell carcinoma (SCC) of the nasal cavity, stage IVA (T4N2M0)... | SCC stage IVA indicates aggressive disease potential.
DiGeorge syndrome impairs immune surveillance, worsening prognosis.
Immunodeficiency increases infection risk post-treatment.
CDKN2A variant suggests potential for tumor suppression loss.
Chemoradiation response is partial, residual disease persists.
Young age gener... | # Prognostic Assessment: Adolescent Nasopharyngeal SCC with Comorbidities
This 16-year-old female with stage IVA poorly differentiated SCC of the nasal cavity, complicated by DiGeorge syndrome and other comorbidities, presents a challenging prognostic scenario. The prognosis is significantly impacted by multiple inter... | prognostic |
Mr. Elias Vance, a 28-year-old male, presents with a well-established diagnosis of Schizoaffective Disorder, Bipolar Type (F25.0 per ICD-10). He was initially diagnosed at age 19 following a first psychotic break characterized by persecutory delusions and auditory hallucinations. His mood episodes are predominantly dep... | Schizoaffective disorder, bipolar type, indicates complex course.
Multiple prior suicide attempts: significant mortality risk.
Treatment resistance suggests poorer long-term outcomes.
Subclinical hypothyroidism may worsen depressive symptoms.
Social isolation exacerbates illness and reduces support.
History of substanc... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case with multiple high-risk factors, making accurate prognosis challenging. His Schizoaffective Disorder, Bipolar Type, coupled with treatment resistance, prior suicide attempts, and significant psychosocial stressors, paints a concerning pictur... | prognostic |
A 28-year-old female presents with known May-Thurner syndrome complicated by chronic deep vein thrombosis (DVT) of the left common iliac vein and inferior vena cava (IVC). She was initially diagnosed at age 25 after presenting with left leg swelling and pain. Initial workup revealed iliac vein compression and DVT. She ... | May-Thurner syndrome: chronic, complex venous obstruction.
Recurrent thrombosis despite stenting: poor initial response.
Factor V Leiden: increased thrombotic risk.
Smoking: endothelial dysfunction, worsens venous disease.
Obesity: contributes to venous hypertension, inflammation.
Non-healing ulcer: advanced chronic ve... | # Prognostic Assessment for a 28-Year-Old Female with May-Thurner Syndrome and Chronic DVT
This patient presents a highly complex case of May-Thurner syndrome complicated by recurrent DVT, chronic venous insufficiency, and multiple risk factors. Prognostic assessment requires considering the interplay of these factors... | prognostic |
A 28-year-old Hispanic male presents with a 3-year history of generalized vitiligo, initially affecting the dorsal hands and feet, now progressing to involve >40% body surface area (BSA), including facial involvement (perioral, periocular). He reports significant psychosocial distress and anxiety related to the visible... | Vitiligo BSA >40% indicates extensive disease severity.
Facial involvement worsens psychosocial impact significantly.
Family history suggests autoimmune predisposition.
Subclinical hypothyroidism may accelerate vitiligo progression.
Asthma indicates potential for systemic inflammation.
Construction work increases UV ex... | # Prognostic Assessment for Generalized Vitiligo
This 28-year-old Hispanic male with generalized vitiligo presents a complex case requiring careful prognostic assessment. His disease is characterized by extensive involvement (>40% BSA), facial involvement, a family history of autoimmunity, and significant psychosocial... | prognostic |
A 72-year-old African American female with a 30-pack-year smoking history presents with worsening abdominal pain, weight loss (15 lbs in 3 months), and new-onset jaundice. She was diagnosed with Stage IIIB (T3N1M0) moderately differentiated adenocarcinoma of the distal common bile duct six months ago, initially treated... | Bile duct cancer recurrence: locally advanced, high risk.
Positive margins, perineural invasion: poor initial prognosis.
BRCA2 mutation: potential sensitivity to PARP inhibitors.
Diabetes, CKD, COPD: comorbidities worsen overall health.
ECOG 1: relatively good functional status currently.
Hepatic artery involvement: li... | # Prognostic Assessment for Recurrent Bile Duct Cancer
This 72-year-old African American female with recurrent, locally advanced bile duct cancer faces a challenging prognosis. Her case is complicated by multiple adverse factors, but also potentially benefits from emerging targeted therapies.
**Short-Term Prognosis (... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a 7-year history of Parkinson’s Disease (PD), now presenting with significant cognitive decline and recurrent falls. He was diagnosed with PD based on UK Brain Bank criteria. His motor symptoms initially responded well to levodopa, but now exhibit significant fluctuatio... | PDD diagnosis confirms neurodegenerative disease progression.
Age 82 increases vulnerability to adverse outcomes.
Rapid MMSE decline indicates accelerated cognitive worsening.
Frequent falls signify increased morbidity and mortality risk.
UPDRS score reflects advanced motor symptom severity.
Comorbid CKD impacts overal... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at high risk for further falls and associated injuries. His cognitive decline will likely continue, potentially leading to increased dependence on his daughter for activities of daily living (ADLs). Acute medi... | prognostic |
A 52-year-old female presents with known hypertrophic cardiomyopathy (HCM), diagnosed 5 years ago via echocardiogram showing maximal left ventricular wall thickness of 2.2cm. She initially was asymptomatic, managed with beta-blockers. Over the past 6 months, she’s developed progressive NYHA class II symptoms (dyspnea o... | HCM severity: Moderate, LVOTO present, symptomatic NYHA II.
High-risk features: LVOTO, myocardial fibrosis, genetic mutation.
PVC burden: Extremely high, increases arrhythmia risk significantly.
Comorbidities: Diabetes, CKD worsen cardiovascular outcomes.
CKD stage 3a: Impacts medication choices, increases mortality.
P... | # Prognostic Assessment for Hypertrophic Cardiomyopathy
This 52-year-old female with HCM presents a complex prognostic challenge due to multiple interacting risk factors. Her case is considered high-risk.
**Short-Term Prognosis (Days to Weeks):**
Her immediate risk is primarily related to symptomatic exacerbation of ... | prognostic |
Mr. David Miller is a 52-year-old male admitted to the ICU following a massive pulmonary embolism (PE) complicated by cardiogenic shock requiring vasopressors and mechanical ventilation. He has a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), chronic kidney disease stage 3 (eGFR 45 mL/min/1.73m2), ... | Massive PE with cardiogenic shock: high initial severity.
CKD stage 3 increases mortality post-PE significantly.
Diabetes complicates recovery and increases infection risk.
Prior DVT suggests underlying hypercoagulable state.
RV dysfunction indicates significant hemodynamic compromise.
SOFA score 12: high risk of ICU m... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is guarded. Despite initial thrombolysis, he remains hemodynamically unstable requiring vasopressors and mechanical ventilation. The risk of early mortality (within 7-14 days) is substantial, estima... | prognostic |
A 7-day-old female infant, born at 30 weeks gestation (birth weight 1.2kg), presents with respiratory distress. She was diagnosed with Bronchopulmonary Dysplasia (BPD) – severe, requiring ongoing mechanical ventilation (oscillatory ventilation). Initial chest X-ray showed diffuse granular opacities. She has a patent du... | Prematurity significantly increases risk of adverse outcomes.
Severe BPD indicates chronic lung injury, poor prognosis.
Large PDA adds cardiac strain, worsens respiratory status.
Grade III IVH correlates with neurodevelopmental impairment.
Maternal diabetes increases neonatal morbidity and mortality.
Negative sepsis cu... | # Prognostic Assessment for a 7-Day-Old Female Infant with BPD, PDA, and IVH
This infant presents a complex case with multiple interacting conditions significantly impacting her prognosis. The combination of extreme prematurity, severe BPD, a large hemodynamically significant PDA, and a Grade III IVH creates a high-ri... | prognostic |
A 28-year-old female presents 6 months post-motor vehicle accident (MVA) resulting in a complex left tibial plateau fracture (Schatzker type IV). Initial management included open reduction and internal fixation (ORIF) with autograft bone supplementation. She initially demonstrated good radiographic healing, but now rep... | Complex fracture, non-union indicates impaired healing capacity.
EDS impacts connective tissue, delaying fracture consolidation.
ACL tear adds instability, worsening functional limitations.
Osteoarthritis development predicts progressive pain and disability.
Quadriceps weakness compromises knee stability and function.
... | # Prognostic Assessment: Complex Tibial Plateau Fracture & ACL Tear with EDS
This 28-year-old female presents a challenging case with multiple factors impacting her orthopedic prognosis. Her complex tibial plateau fracture, non-union, ACL tear, and underlying EDS create a complex interplay of biomechanical and systemi... | prognostic |
A 16-year-old male, 'Ethan', is admitted following a deliberate overdose of diphenhydramine (estimated 1.5g) and pseudoephedrine (estimated 600mg) ingested approximately 4 hours prior to arrival. He has a history of moderate persistent asthma, poorly controlled, requiring frequent albuterol inhaler use (average 4 times... | Diphenhydramine/pseudoephedrine overdose: moderate-severe presentation.
Pre-existing asthma: increases respiratory complication risk.
GAD & poor sertraline adherence: suggests mental health instability.
QTc prolongation: arrhythmia risk, potentially life-threatening.
Social isolation/bullying: ongoing psychosocial stre... | # Prognostic Assessment for Ethan – Diphenhydramine/Pseudoephedrine Overdose
**Short-Term Prognosis (Days to Weeks):**
Ethan’s short-term prognosis is guarded. While the initial resuscitation has been successful, he remains at risk for cardiac arrhythmias due to QTc prolongation. The combination of diphenhydramine and... | prognostic |
Mrs. Eleanor Vance is a 72-year-old female presenting with worsening dyspnea and peripheral edema. She was diagnosed with Stage III (T2N1M0) HER2-negative, hormone receptor-positive invasive ductal carcinoma of the right breast 3 years ago and completed adjuvant chemotherapy (doxorubicin/cyclophosphamide followed by pa... | Breast cancer history impacts cardiac function significantly.
Chemotherapy-induced cardiomyopathy is highly probable.
CKD exacerbates fluid overload and cardiac stress.
Diabetes increases cardiovascular disease risk further.
LVEF 35% indicates severe systolic dysfunction.
Pleural effusions suggest advanced heart failur... | # Prognostic Assessment for Mrs. Eleanor Vance
Mrs. Vance presents a complex case with interacting conditions significantly impacting her prognosis. Her underlying breast cancer treatment history, coupled with pre-existing comorbidities and recent decline in functional status, necessitates a nuanced assessment.
**Sho... | prognostic |
A 7-day-old male infant, born at 28 weeks gestation (birth weight 850g), initially presented with respiratory distress syndrome (RDS) requiring surfactant administration and mechanical ventilation. He developed bronchopulmonary dysplasia (BPD) – severe, requiring prolonged oxygen support. He also has patent ductus arte... | Extreme prematurity significantly worsens overall prognosis.
Severe BPD indicates chronic lung injury, poor outcomes.
Hemodynamically significant PDA adds cardiac strain.
Pulmonary hypertension complicates respiratory management.
Grade 3 IVH increases risk of neurodevelopmental delay.
Recurrent apnea suggests neurologi... | # Prognostic Assessment for a 7-Day-Old Male Infant with BPD, PDA, IVH, and Prematurity
This infant presents a complex case with multiple interacting conditions significantly impacting his prognosis. The combination of extreme prematurity, severe BPD, a large PDA, pulmonary hypertension, and a grade 3 IVH creates a hi... | prognostic |
A 28-year-old female, previously healthy, presents with a 6-month history of progressively worsening dyspnea on exertion, non-productive cough, and fatigue. Initial workup revealed bilateral hilar lymphadenopathy and interstitial lung disease on chest CT. Biopsy confirmed Stage II sarcoidosis (bilateral hilar lymphaden... | Stage II sarcoidosis indicates moderate disease severity.
Prednisone failure suggests poor initial response.
Methotrexate intolerance limits treatment options.
Restrictive cardiomyopathy adds cardiac comorbidity.
Reduced FVC/DLCO signifies progressive lung fibrosis.
Limited 6MWD indicates significant functional impairm... | # Prognostic Assessment for Stage II Sarcoidosis with Cardiac Involvement
This 28-year-old female with Stage II sarcoidosis presents a complex prognostic challenge due to multiple interacting factors. Her disease course has been complicated by steroid resistance, methotrexate intolerance, and the development of restri... | prognostic |
Mr. David Chen, a 48-year-old Asian American male, presents with a well-established diagnosis of Bipolar I Disorder, most recent manic episode 6 months ago, currently in remission on Lithium 900mg daily and Quetiapine 300mg nightly. He has a 20-year history of the illness, characterized by rapid cycling (4-5 episodes p... | Bipolar I, rapid cycling history indicates poorer prognosis.
Long illness duration suggests treatment resistance potential.
Substance use history increases relapse vulnerability.
Family history of suicide is a significant risk factor.
Social isolation exacerbates illness course and recovery.
Hypertension adds to overal... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of Bipolar I Disorder with multiple factors influencing his prognosis. His long illness duration, history of rapid cycling, and family history of suicide significantly elevate his risk for future episodes and adverse outcomes.
**Short-Term Pr... | prognostic |
A 2.5-year-old male presents with a 6-month history of progressively worsening, intensely pruritic, erythematous plaques primarily affecting the flexural areas (popliteal, antecubital fossae), face, and neck. Diagnosis of severe atopic dermatitis (AD) confirmed by dermatology. He has failed topical corticosteroids (up ... | Severe AD, high SCORAD/EASI indicates significant disease burden.
Early-onset AD, multiple allergen sensitivities worsen prognosis.
Family history of atopy increases risk of chronic disease.
Failed topical therapies suggest treatment resistance potential.
Congenital heart defect adds comorbidity, impacting management.
... | # Prognostic Assessment for Severe Atopic Dermatitis in a Toddler
This 2.5-year-old male with severe AD presents a complex prognostic challenge due to multiple interacting factors. His disease is characterized by early onset, widespread involvement, treatment resistance, and significant impact on quality of life.
**S... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents with Stage IV HER2-positive breast cancer, initially diagnosed 6 months ago. Primary tumor was 6cm, with axillary lymph node involvement (positive, >4 nodes). She has metastatic disease to the bone (multiple vertebral lesions) and liver (multiple lesions, largest 3cm). Sh... | Stage IV HER2+ breast cancer indicates poor prognosis.
Visceral metastases (liver, bone) worsen outlook significantly.
Partial response to neoadjuvant therapy is encouraging.
Disease progression post-chemotherapy is concerning.
ECOG 1 suggests moderate functional impairment.
Depression and anxiety impact treatment adhe... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of metastatic HER2-positive breast cancer requiring a nuanced prognostic assessment. Her young age is a potentially favorable factor, but is significantly offset by the extent of her disease and several high-risk features.
**Short-Term Pro... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female with a 5-year history of Parkinson’s Disease (PD), Hoehn & Yahr stage III, presenting with worsening motor fluctuations and new cognitive impairment. She lives alone, previously independent, but now requires assistance with medication management and meal preparatio... | PD stage III indicates moderate disease severity.
LRRK2 mutation suggests potentially faster progression.
Cognitive decline points towards Parkinson’s Disease Dementia.
Falls increase risk of morbidity and mortality.
Orthostatic hypotension complicates management and increases risk.
Diabetes and hypertension impact ove... | # Prognostic Assessment for Mrs. Elena Rodriguez
Mrs. Rodriguez presents a complex case with multiple interacting factors influencing her prognosis. Her established Parkinson’s Disease, complicated by dementia, falls, orthostatic hypotension, and comorbidities, necessitates a nuanced assessment.
**Short-Term Prognosi... | prognostic |
A 16-year-old male, 'Ethan', is admitted following a deliberate overdose of dicyclomine (Bentyl) 2 grams, ingested approximately 6 hours prior to arrival. He has a history of functional abdominal pain syndrome (FAPS) diagnosed 2 years ago, complicated by significant anxiety and depressive symptoms, currently untreated.... | Dicyclomine overdose: severe anticholinergic toxidrome present.
Significant ingestion amount: 2 grams, high toxicity potential.
Comorbid anxiety/depression: complicates management, prognosis.
Untreated mental health: increases risk of recurrence/completion.
Functional abdominal pain: chronic pain impacts recovery.
Phys... | # Prognostic Assessment for Ethan – Dicyclomine Overdose
**Short-Term Prognosis (Days to Weeks):**
Ethan’s short-term prognosis is guarded. While the initial acute anticholinergic effects were partially reversed with physostigmine, the recurrence of symptoms indicates persistent toxicity. The primary concerns are ongo... | prognostic |
A 9-month-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress. He was diagnosed with congenital diaphragmatic hernia (CDH) – Bochdalek type – at 20 weeks gestation via prenatal ultrasound. Initial repair was performed at 3 days of age, but developed severe pulm... | CDH severity: large defect, late presentation, PHTN persistence.
Prematurity increases respiratory morbidity and long-term issues.
PHTN severity: high PAP, RV hypertrophy, poor response.
GERD contributes to aspiration risk and respiratory compromise.
Frequent infections indicate immune dysfunction, worsening prognosis.... | # Prognostic Assessment for Infant with Congenital Diaphragmatic Hernia (CDH)
This 9-month-old infant with CDH, persistent PHTN, prematurity, and a *FOXF1* mutation presents a complex prognostic challenge. His clinical course has been complicated by recurrent respiratory distress, failure to thrive, and developmental ... | prognostic |
Mr. David Miller is a 28-year-old male admitted to the psychiatric unit following a suicide attempt involving a significant overdose of lorazepam and alcohol. He has a confirmed diagnosis of Bipolar I Disorder, most recent manic episode 6 months prior, currently experiencing a mixed depressive episode with psychotic fe... | Bipolar I, mixed depression with psychosis: severe presentation.
Multiple prior attempts: significantly increased suicide risk.
Childhood trauma: adverse childhood experiences impact prognosis.
Substance use disorder: complicates treatment and recovery.
Poor medication adherence: reduces treatment effectiveness.
Lack o... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is guarded. He remains at high risk for further suicide attempts despite admission and initial stabilization. The acute psychotic features and severe depressive symptoms require aggressive treatment... | prognostic |
Mr. Elias Vance is a 68-year-old African American male with a 7-year history of established Rheumatoid Arthritis (RA). He initially presented with symmetrical polyarthritis affecting small and large joints. He was initially treated with methotrexate, but due to intolerance (gastrointestinal side effects), he transition... | Established RA, moderate activity, long disease duration.
TNF inhibitor failure suggests poor long-term response.
Erosions indicate aggressive disease, poorer prognosis.
Anemia likely inflammatory, contributes to fatigue.
Comorbidities (HTN, DM) increase cardiovascular risk.
Functional limitations impact quality of lif... | # Prognostic Assessment for Mr. Elias Vance
**Short-Term Prognosis (Days to Weeks):**
Mr. Vance is at risk for continued pain and functional decline if current treatment remains unchanged. He may experience flares of his RA, exacerbating his fatigue and ADL limitations. There is a moderate risk of infection related to... | prognostic |
A 48-year-old female presents with a known diagnosis of Chronic Myeloid Leukemia (CML) in chronic phase, diagnosed 3 years ago. She initially responded well to first-line imatinib therapy, achieving a complete cytogenetic response within 6 months. However, over the past 6 months, she has experienced increasing fatigue,... | CML phase transition: chronic to accelerated/blast phase.
Rising BCR-ABL1 transcript levels indicate imatinib resistance.
Blast percentage increase suggests worsening disease burden.
Comorbid diabetes impacts treatment tolerance/outcomes.
Prior DVT increases bleeding risk with intensive therapy.
Psychosocial distress a... | # Prognostic Assessment for Chronic Myeloid Leukemia (CML)
This 48-year-old female with CML demonstrates concerning signs of disease progression despite prior imatinib response. Her case is complicated by comorbidities and psychosocial factors, necessitating a nuanced prognostic assessment.
**Short-Term Prognosis (Da... | prognostic |
A 28-year-old Hispanic female presents 6 months post-motor vehicle accident resulting in a closed, comminuted fracture of the left tibial plateau (Schatzker type IV). Initial treatment involved open reduction and internal fixation (ORIF) with a complex plate and screw construct. She underwent staged reconstruction incl... | Complex tibial plateau fracture, significant cartilage damage.
Comorbid diabetes impairs healing, increases infection risk.
Young age, high pre-injury activity level considered.
Allograft cartilage has variable long-term success rates.
Family history suggests genetic predisposition to OA.
COL2A1 heterozygosity increase... | # Prognostic Assessment: Tibial Plateau Fracture with Post-Traumatic Osteoarthritis
**Short-Term Prognosis (Days to Weeks):**
Expect continued pain and limited function. Achieving significant improvements in range of motion and pain control within the next few weeks is unlikely without further intervention. Risk of in... | prognostic |
A 9-year-old female presents with a 6-month history of progressive vision loss in her left eye. Initial examination revealed a suspected retinoblastoma. Diagnostic imaging (MRI and ultrasound) confirmed a unilateral, endophytic retinoblastoma involving the macula and extending to the vitreous base. The tumor measures 1... | Endophytic tumor, macular involvement: poor prognostic indicators.
Choroidal invasion signifies aggressive disease progression.
Large cell undifferentiated component: increased metastatic risk.
Unilateral presentation: generally better than bilateral.
Age under 10: favorable response to chemotherapy.
Anxiety impacts tr... | # Prognostic Assessment for Retinoblastoma
This 9-year-old patient presents with a high-risk unilateral retinoblastoma. Prognostic assessment is complex due to the aggressive tumor characteristics, but also influenced by her overall health and psychosocial factors.
**Short-Term Prognosis (Days to Weeks):**
The immedi... | prognostic |
Mrs. Eleanor Vance is a 72-year-old female admitted for worsening shortness of breath. She has a history of Stage III Chronic Obstructive Pulmonary Disease (GOLD classification) with frequent exacerbations, ischemic heart disease (post-MI 5 years ago, one stent placed), hypertension, type 2 diabetes mellitus (poorly co... | COPD stage III, frequent exacerbations, poor prognosis.
Ischemic heart disease increases cardiovascular risk significantly.
Poorly controlled diabetes accelerates disease progression.
Chronic kidney disease limits treatment options, worsens outcomes.
Mild cognitive impairment impacts self-management ability.
Living alo... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance’s short-term prognosis is guarded. She is at high risk for further respiratory decompensation requiring hospitalization or even ICU admission. The current exacerbation of COPD, coupled with underlying heart failure, inc... | prognostic |
Eleven-year-old female, Maya, presents with established Juvenile Idiopathic Arthritis (JIA), specifically systemic JIA, diagnosed 2 years ago. Initial presentation included daily spiking fevers, evanescent rash, and arthritis affecting knees, wrists, and ankles. She initially responded well to IL-1 blockade (canakinuma... | Systemic JIA: active disease despite current therapy.
Elevated inflammatory markers indicate ongoing inflammation.
Ferritin >500 suggests macrophage activation syndrome risk.
Hepatosplenomegaly raises concern for systemic involvement.
Asthma: potential for increased respiratory complications.
Family history: genetic pr... | # Prognostic Assessment for Maya – Systemic JIA
**Short-Term Prognosis (Days to Weeks):**
Maya is at immediate risk for Macrophage Activation Syndrome (MAS) given her elevated ferritin, persistent fevers, and systemic inflammation. Without prompt intervention, MAS can rapidly progress to multi-organ failure and death.... | prognostic |
A 9-year-old female of mixed African and European ancestry presents with a 3-year history of generalized vitiligo, initially presenting as small, depigmented macules on her hands and feet. The disease has progressed significantly, now affecting >60% of her body surface area (BSA), including facial involvement (perioral... | High BSA involvement indicates aggressive disease course.
Early onset suggests potentially more extensive progression.
African ancestry linked to more severe vitiligo outcomes.
Anti-TPO positivity signals autoimmune predisposition.
Atopic dermatitis may influence treatment response.
Psychosocial impact significantly af... | # Prognostic Assessment for Generalized Vitiligo
This 9-year-old patient with generalized vitiligo presents a complex case requiring careful prognostic assessment. Her disease characteristics, genetic background, comorbidities, and psychosocial factors all contribute to a nuanced outlook.
**Short-Term Prognosis (Days... | prognostic |
A 16-year-old African American male, Jamal, presents with a 3-year history of severe, uncontrolled asthma, initially diagnosed at age 13. He experiences frequent exacerbations (average 6 per year) requiring emergency department visits and systemic corticosteroids. His asthma is characterized by significant nocturnal sy... | Severe asthma, frequent exacerbations indicate poor control.
Early-onset asthma, family history worsen long-term outlook.
EoE adds to systemic inflammation, impacting airway health.
Airway remodeling suggests fixed airflow obstruction development.
Low socioeconomic status, pollution increase exacerbation risk.
Psychoso... | # Prognostic Assessment for Jamal – Severe Asthma
**Short-Term Prognosis (Days to Weeks):**
Jamal is at high risk for near-future asthma exacerbations requiring emergency department visits or hospitalization. His current medication regimen, while high-dose, demonstrates limited control. The presence of ongoing symptom... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), hypertension (well-controlled on amlodipine 10mg daily), hyperlipidemia (LDL 160mg/dL despite atorvastatin 40mg daily), and a 40-pack-year smoking history (quit 5 years ago). He presented 3 weeks ago w... | Established PAD severity: significant limb ischemia, low ABI.
Diabetes poorly controlled: accelerates atherosclerosis, impairs healing.
Hyperlipidemia uncontrolled: contributes to plaque instability.
Smoking history: substantial vascular damage, increased risk.
CKD stage 3a: increases cardiovascular risk, limits interv... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a high-risk scenario for adverse cardiovascular and limb-related events. His established PAD, complicated by acute limb ischemia and residual non-transferable ischemia, coupled with significant comorbidities, necessitates a detailed prognostic a... | prognostic |
A 52-year-old African American female, Ms. Evelyn Reed, presents with Stage IIIB (T3N2M0) HER2-positive invasive ductal carcinoma of the left breast, diagnosed 6 months ago. She initially underwent neoadjuvant chemotherapy (AC-T regimen) followed by lumpectomy and sentinel lymph node biopsy revealing residual disease i... | Stage IIIB HER2+ breast cancer: aggressive disease.
BRCA1 mutation: increased recurrence risk, poorer survival.
Residual disease post-chemotherapy: unfavorable prognostic indicator.
Axillary FDG uptake: suggests local recurrence/persistent disease.
Lymphedema: impacts quality of life, potential infection risk.
Hyperten... | # Prognostic Assessment for Ms. Evelyn Reed
Ms. Reed presents a complex case with multiple factors influencing her prognosis. Her Stage IIIB HER2-positive breast cancer, despite initial treatment, carries a significant risk of recurrence and mortality. The presence of a BRCA1 mutation further worsens her prognosis, in... | prognostic |
A 16-year-old male, previously healthy, presents post-motor vehicle collision (MVC) with a complete spinal cord injury (SCI) at C4-C5. Initial assessment reveals complete motor and sensory loss below C5. He sustained a fractured C4 vertebra with spinal cord compression confirmed by MRI. He also has a closed head injury... | Complete C4-C5 SCI indicates severe neurological deficit.
Age is a positive prognostic factor for neurorecovery.
Complete injury limits spontaneous functional return.
Head injury complicates recovery, potential cognitive impact.
Ventilator dependence increases infection and morbidity risk.
Pressure ulcer signals compro... | # Prognostic Assessment for a 16-Year-Old Male with C4-C5 Complete SCI
This case presents a complex prognostic challenge due to the severity of the injury, presence of comorbidities, and the adolescent patient's developmental stage. The complete nature of the SCI at C4-C5 significantly impacts the prognosis.
**Short-... | prognostic |
Mr. David Chen, a 52-year-old African American male, presents with a 6-month history of progressively worsening vision in his left eye. He was diagnosed 3 months ago with proliferative diabetic retinopathy (PDR) in the left eye, stage P2, based on fundus photography and fluorescein angiography. He has a 20-year history... | PDR stage P2 indicates moderate severity, high progression risk.
Poor glycemic control significantly worsens retinopathy outcomes.
Smoking accelerates diabetic retinopathy progression substantially.
Hypertension contributes to retinal vascular damage.
Macular edema impacts visual acuity, limits recovery.
CKD exacerbate... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of proliferative diabetic retinopathy with multiple high-risk factors impacting his prognosis. His case requires a nuanced assessment considering both ocular and systemic factors, as well as psychosocial influences.
**Short-Term Prognosis (Da... | prognostic |
A 16-year-old male, Jamal, presents with a 6-month history of progressive vision loss in his left eye. He was initially diagnosed with retinitis pigmentosa (RP) based on clinical examination (constricted visual fields, attenuated retinal vessels, waxy pallor of the optic disc) and full-field electroretinography (ERG) d... | RP severity: homozygous *RHO* mutation indicates aggressive form.
Age of onset: early onset (16yo) predicts faster progression.
Visual acuity: significant left eye loss, impacting function.
OCT findings: macular thinning suggests central vision decline.
Family history: maternal grandfather’s early RP is relevant.
Comor... | # Prognostic Assessment for Jamal – Retinitis Pigmentosa
**Short-Term Prognosis (Days to Weeks):**
Jamal will likely experience continued, albeit potentially slow, decline in visual function in his left eye. Central visual acuity will likely worsen, impacting reading and detailed tasks. He will require ongoing support... | prognostic |
Mr. Elias Vance is a 93-year-old male with a history of ischemic heart disease (prior MI 10 years ago, status post PCI to LAD), chronic kidney disease stage 3b (eGFR 35 mL/min/1.73m²), type 2 diabetes mellitus (HbA1c 7.8%), and moderate chronic obstructive pulmonary disease (GOLD stage 2). He presents with worsening dy... | Severe MR significantly impacts cardiac output and prognosis.
Advanced age increases baseline risk of adverse events.
CKD stage 3b limits intervention options and increases risk.
Diabetes exacerbates cardiovascular disease progression.
COPD contributes to functional limitations and mortality.
Reduced EF indicates signi... | # Prognostic Assessment for Mr. Elias Vance
**Short-Term Prognosis (Days to Weeks):**
Mr. Vance is at high risk for near-term hospitalization due to heart failure exacerbation. The combination of severe mitral regurgitation, reduced left ventricular function, and chronic kidney disease creates a precarious hemodynamic... | prognostic |
A 28-year-old African American female, Ms. Anya Sharma, presents with a confirmed diagnosis of Idiopathic Pulmonary Fibrosis (IPF) established via HRCT and surgical lung biopsy 6 months ago. She initially presented with progressive dyspnea on exertion and a dry cough. Her disease has rapidly progressed despite initiati... | Rapid FVC decline indicates aggressive disease progression.
Smoking history contributes to lung damage and prognosis.
SLE and prednisone impact immune function and infection risk.
MUC5B mutation signifies increased IPF severity and progression.
Significant desaturation during 6MWT worsens prognosis.
Anxiety/depression ... | # Prognostic Assessment for Ms. Anya Sharma – Idiopathic Pulmonary Fibrosis
**Short-Term Prognosis (Days to Weeks):** Ms. Sharma is at risk for acute exacerbations of IPF (AE-IPF) given her rapid disease progression and underlying SLE (potentially increasing infection risk). Her oxygen saturation desaturation during e... | prognostic |
A 16-year-old female, Sarah, presents with Stage IIIB Hodgkin Lymphoma, classical Hodgkin lymphoma, nodular sclerosis subtype. Diagnosis confirmed by lymph node biopsy. She has bulky mediastinal disease (Deauville score 4 on initial PET/CT). Her B symptoms include intermittent fevers and night sweats, present for the p... | Stage IIIB indicates advanced disease, poorer prognosis.
Bulky disease worsens prognosis, treatment response crucial.
B symptoms signify higher tumor burden, aggressive disease.
Asthma: potential for treatment-related pulmonary toxicity.
ECOG 1: relatively good functional status, positive factor.
Anemia & elevated LDH:... | # Prognostic Assessment for Sarah - Stage IIIB Hodgkin Lymphoma
**Short-Term Prognosis (Days to Weeks):**
Sarah's immediate prognosis is focused on initiating and tolerating chemotherapy. The primary risk in the short term is treatment-related toxicity, particularly given her asthma. She is at risk for chemotherapy-in... | prognostic |
A 16-year-old male presents with a 6-month history of recurrent, severe infections (pneumonia, sinusitis, skin abscesses). He was diagnosed with Chronic Granulomatous Disease (CGD) due to a mutation in *CYBB* (gp91phox deficiency) confirmed by dihydrorhodamine (DHR) flow cytometry showing <5% neutrophil oxidative burst... | CGD severity: gp91phox deficiency indicates severe oxidative dysfunction.
Recurrent infections: Reflects impaired immune clearance, poor prognosis.
Aspergillus history: High risk for disseminated fungal disease.
Crohn’s disease: Increases infection risk, complicates management.
Infliximab use: Immunosuppression exacerb... | # Prognostic Assessment for Chronic Granulomatous Disease (CGD) with Comorbidities
This 16-year-old male with CGD presents a complex case with multiple factors influencing his prognosis. His *CYBB* mutation indicates a severe form of the disease, and his history is marked by significant morbidity.
**Short-Term Progno... | prognostic |
A 28-year-old female presents with a 3-year history of generalized vitiligo, initially affecting the dorsal hands and feet, now progressing to involve >50% body surface area (BSA). She reports significant psychosocial distress and functional impairment due to visible skin lesions. Examination reveals extensive depigmen... | Vitiligo BSA >50% indicates severe disease extent.
Periorificial involvement suggests aggressive, poor prognosis.
Family history of autoimmunity increases risk of progression.
Subclinical hypothyroidism: autoimmune comorbidity, potential impact.
Crohn’s disease/azathioprine: immunosuppression, treatment complexity.
DLQ... | # Prognostic Assessment for Generalized Vitiligo
This 28-year-old female with extensive, non-segmental vitiligo presents a challenging prognostic scenario due to multiple high-risk factors.
**Short-Term Prognosis (Days to Weeks):**
Continued, albeit potentially slower, disease progression is likely. Psychosocial di... | prognostic |
A 28-year-old male presents with a confirmed diagnosis of high-risk Acute Myeloid Leukemia (AML) with t(15;17) translocation (Acute Promyelocytic Leukemia - APL), currently in complete remission after induction chemotherapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). He achieved morphological remiss... | APL remission, MRD positive indicates relapse risk.
t(15;17) generally favorable, but MRD impacts outcome.
Crohn’s disease complicates treatment, increases infection risk.
Prior DVT/post-thrombotic syndrome: bleeding/thrombosis risk.
Smoking worsens overall health, treatment tolerance.
ECOG 1: good functional status, p... | # Prognostic Assessment for APL in Remission with MRD
This 28-year-old male with APL in remission, but with persistent MRD, presents a complex prognostic scenario. His case is complicated by pre-existing Crohn’s disease, a history of DVT, and lifestyle factors (smoking).
**Short-Term Prognosis (Days to Weeks):**
Rel... | prognostic |
A 16-year-old Hispanic male presents with a known diagnosis of Stage III Hodgkin Lymphoma, Classical Hodgkin Lymphoma, nodular sclerosis subtype, diagnosed 6 months prior. Initial staging CT scans showed bulky mediastinal disease with involvement of cervical and axillary lymph nodes. He completed 6 cycles of ABVD chemo... | Stage III Hodgkin’s, incomplete response to ABVD chemotherapy.
Bulky residual disease indicates unfavorable prognosis.
Deauville 4 post-treatment: treatment failure risk high.
NF1 heterozygosity: increased secondary malignancy risk.
Family history of CVD: potential cardiac toxicity concern.
Asthma: manageable, but impa... | # Prognostic Assessment for a 16-Year-Old Male with Relapsed/Refractory Hodgkin Lymphoma
This case presents a complex scenario with a high risk of treatment failure and long-term complications. The patient’s incomplete response to ABVD chemotherapy, evidenced by persistent bulky disease and a Deauville score of 4 on P... | prognostic |
A 9-year-old male, previously healthy, presents with a 3-month history of fatigue, pallor, and easy bruising. Initial workup revealed acute myeloid leukemia (AML) with monosomy 7 and FLT3-ITD mutation. Bone marrow aspirate and biopsy confirmed >80% blasts. He was induced with cytarabine and daunorubicin, achieving morp... | AML relapse post-allo-HSCT: high-risk scenario.
Monosomy 7: adverse cytogenetic risk factor.
FLT3-ITD mutation: associated with higher relapse.
MRD positive post-induction: poor prognostic indicator.
GVHD history: impacts treatment options/toxicity.
Rising blast count: indicates aggressive relapse.
Chronic lung disease... | # Prognostic Assessment for Relapsed AML Post-allo-HSCT
This 9-year-old patient with relapsed AML following allogeneic HSCT presents a complex and concerning clinical picture. His prognosis is significantly guarded due to multiple high-risk factors.
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is... | prognostic |
A 28-year-old male with a history of cystic fibrosis (CF) presents to the ICU with acute respiratory failure secondary to *Pseudomonas aeruginosa* pneumonia and subsequent ARDS. He was diagnosed with CF at age 5 (deltaF508 homozygous mutation). He has chronic *P. aeruginosa* colonization, pancreatic insufficiency requi... | ARDS severity assessed: moderate, impacting short-term survival.
Post-transplant status: increases infection and rejection risk.
Chronic Pseudomonas colonization: contributes to lung injury.
CFRD complicates recovery, increasing infection susceptibility.
Renal dysfunction: suggests acute kidney injury, poor prognosis.
... | # Prognostic Assessment for 28-Year-Old Male with CF Post-Lung Transplant
This patient presents a complex case with multiple interacting factors significantly impacting his prognosis. His recent acute respiratory failure, superimposed on a background of chronic CF, post-lung transplant status, and multiple comorbiditi... | prognostic |
A 16-year-old Hispanic male presents with a confirmed diagnosis of Standard Risk Acute Lymphoblastic Leukemia (ALL), B-cell precursor, achieved complete remission after induction chemotherapy based on bone marrow aspirate (<5% blasts). He completed consolidation therapy. He has a high white blood cell count at diagnosi... | ALL remission status: achieved, but MRD positive.
High initial WBC count: indicates higher disease burden.
Positive MRD: significant relapse risk indicator.
Asthma: potential chemotherapy complication risk.
Obesity: impacts treatment tolerance and outcomes.
ECOG 0: good functional status, positive prognosticator.
*NOD2... | # Prognostic Assessment for Standard Risk ALL in Remission
**Short-Term Prognosis (Days to Weeks):**
The patient's current fatigue warrants immediate investigation. While not definitively indicative of relapse, it raises concern. Short-term prognosis is cautiously guarded. A repeat bone marrow aspirate and MRD assess... | prognostic |
A 2.5-year-old female of Ashkenazi Jewish descent presents with a confirmed diagnosis of Juvenile Myelomonocytic Leukemia (JMML), specifically with a *RAS* pathway mutation (NRAS Q61R). She was initially diagnosed 3 months ago after presenting with pallor, recurrent infections (otitis media, pneumonia), and hepatosplen... | JMML severity: increasing blasts indicate worsening disease.
RAS mutation: associated with poorer prognosis in JMML.
Age <3 years: generally better response to treatment.
LPPS 60%: significantly reduced functional status.
Comorbidity: ASD adds complexity, potential for complications.
CKD stage 2: limits treatment optio... | # Prognostic Assessment for Juvenile Myelomonocytic Leukemia (JMML)
This 2.5-year-old female with JMML presents a complex prognostic scenario due to multiple interacting factors. Her *RAS* pathway mutation (NRAS Q61R) is a significant negative prognostic indicator. While younger age (<3 years) is generally associated ... | prognostic |
A 2.5-year-old female presents with a confirmed diagnosis of Stage IV Neuroblastoma, MYCN-amplified, originating in the adrenal gland. Initial presentation included bilateral periorbital hematomas, bone pain, and abdominal distension. Imaging revealed widespread metastatic disease to bone marrow, liver, and multiple sk... | Stage IV neuroblastoma indicates aggressive disease course.
MYCN amplification worsens prognosis significantly.
Congenital heart disease adds comorbidity complexity.
Recurrent infections suggest immune dysfunction.
ECOG 2 reflects reduced functional capacity.
Psychosocial stress impacts treatment adherence.
ALK variant... | # Prognostic Assessment: Stage IV Neuroblastoma
This 2.5-year-old female with Stage IV, MYCN-amplified neuroblastoma presents a complex prognostic scenario. Multiple factors contribute to a guarded outlook.
**Short-Term Prognosis (Days to Weeks):** The immediate prognosis is concerning due to significant myelosuppres... | prognostic |
An 8-year-old female presents with a 6-month history of progressive vision loss in her left eye. Initial examination revealed a suspected retinoblastoma. Subsequent MRI and fundus examination confirmed unilateral, endophytic retinoblastoma involving the macula and optic nerve head in the left eye. The tumor measures 15... | Endophytic tumor, macula/optic nerve involvement: poor prognosis.
Choroidal invasion signifies aggressive tumor behavior.
Large tumor size (15mm) increases treatment difficulty.
No germline *RB1* mutation: sporadic, potentially less aggressive.
Unilateral disease: better than bilateral presentation.
ECOG 0: good overal... | # Prognostic Assessment for Retinoblastoma
This 8-year-old patient with unilateral, endophytic retinoblastoma presents a complex prognostic scenario. The presence of choroidal invasion and involvement of the macula and optic nerve head significantly worsen the prognosis. While the absence of a germline *RB1* mutation ... | prognostic |
A 28-year-old African American male presents with a known diagnosis of high-risk non-muscle invasive bladder cancer (NMIBC), specifically T1G3, high-grade urothelial carcinoma, following transurethral resection of bladder tumor (TURBT) 6 months ago. Initial cystoscopy revealed a single, 3cm tumor involving the lateral ... | High-grade, T1G3 NMIBC indicates aggressive potential.
BCG failure signifies increased risk of progression.
CIS at margins suggests incomplete tumor removal.
Sickle cell trait may impact treatment tolerance.
Smoking worsens bladder cancer prognosis significantly.
BRCA2 mutation suggests DNA repair deficiency.
ECOG 1 in... | # Prognostic Assessment for High-Risk NMIBC
This 28-year-old African American male with BCG-refractory, high-risk NMIBC faces a challenging prognosis. Multiple factors contribute to a significantly elevated risk of disease progression and potential mortality.
**Short-Term Prognosis (Days to Weeks):**
Relatively stabl... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a history of chronic obstructive pulmonary disease (COPD) – GOLD Stage 4, poorly controlled hypertension, and a prior myocardial infarction (MI) 5 years ago. He presented to the emergency department with worsening dyspnea and was found to have a large, centrally located... | Advanced stage NSCLC indicates poor inherent prognosis.
Brain metastasis signifies aggressive disease course.
PD-L1 20% suggests potential immunotherapy benefit.
COPD exacerbates respiratory compromise, limiting treatment.
Prior MI increases cardiovascular risk during therapy.
Age 82 impacts tolerance to aggressive int... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Established Diagnosis:** Stage IV Adenocarcinoma of the Lung (T2aN2M1b) with Brain and Adrenal Metastases.
**Short-Term Prognosis (Days to Weeks):** Mr. Penhaligon’s immediate prognosis is guarded. The brain metastasis is causing symptomatic neurological deficits (d... | prognostic |
Mr. David Chen, a 28-year-old African American male, presents for follow-up 6 months post-acute myocardial infarction (STEMI) secondary to cocaine-induced coronary vasospasm. He has a history of poorly controlled hypertension (diagnosed at age 22), hyperlipidemia (diagnosed at age 25), and a family history of premature... | Young age, STEMI complicates prognosis significantly.
Cocaine use: ongoing vasospastic risk, poor adherence.
OUD treatment adherence impacts overall health outcomes.
Hypertension, hyperlipidemia: accelerate atherosclerosis.
LV dysfunction: increased risk of heart failure, arrhythmia.
Microvascular dysfunction: limits r... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at moderate risk for near-term adverse events. The primary concerns are recurrent ischemic events due to continued cocaine use, worsening heart failure symptoms, and potential arrhythmias. His BNP level suggests ongoing my... | prognostic |
A 52-year-old female presents with worsening symptoms of Crohn's disease, diagnosed 15 years ago. Initially ileal disease, it has progressed to involve the entire colon and now demonstrates stricturing and fistulizing behavior. She has failed multiple biologic therapies (infliximab, adalimumab, vedolizumab) and is curr... | Crohn’s disease: severe, extensive, and treatment-refractory.
Multiple biologic failures indicate poor disease responsiveness.
Strictures and fistulas suggest complicated disease course.
Malnutrition worsens prognosis, increases complication risk.
DVT history limits surgical options, increases bleeding risk.
Functional... | # Prognostic Assessment for Crohn's Disease
This 52-year-old female with long-standing, treatment-refractory Crohn's disease presents a complex prognostic challenge. Her disease is severe, extensive, and complicated by strictures, fistulas, and malnutrition. Multiple failed biologics and current upadacitinib use sugge... | prognostic |
Ethan, an 8-year-old male, presents with a confirmed diagnosis of Cystic Fibrosis (CF) diagnosed at age 2 following a positive newborn screen and sweat chloride testing. He is compound heterozygous for the F508del/W1282X mutations. He has experienced chronic respiratory symptoms including persistent cough, frequent exa... | CFTR mutation genotype: F508del/W1282X – poor prognosis.
FEV1 65% predicted: indicates moderate lung disease severity.
Chronic *Burkholderia dolosa*: associated with faster decline.
CFRD presence: accelerates disease progression, complications.
Aspergillus colonization: increased risk of allergic bronchopulmonary asper... | # Prognostic Assessment for Ethan – Cystic Fibrosis
**Short-Term Prognosis (Days to Weeks):**
Ethan is at moderate risk for an acute pulmonary exacerbation requiring hospitalization within the next few weeks, particularly given the recent *Aspergillus* colonization and ongoing *Burkholderia dolosa* infection. His CFRD... | prognostic |
A 48-year-old African American female with a 12-year history of Type 2 Diabetes Mellitus (HbA1c consistently 8.5-9.5%) and poorly controlled hypertension (average BP 150/90 mmHg despite multiple medications) presents with worsening lower extremity edema and fatigue over the past 6 months. She was diagnosed with IgA nep... | IgA nephropathy progression with crescentic features: severe.
Diabetes and hypertension: accelerate kidney disease progression.
Low eGFR (25 mL/min): indicates stage 4 CKD.
High proteinuria (4.5 g/g): predicts faster decline.
Anemia (Hb 10.5): common in CKD, impacts quality of life.
Hyperphosphatemia (5.5): early sign ... | # Prognostic Assessment for IgA Nephropathy with Crescentic Glomerulonephritis
This 48-year-old African American female with IgA nephropathy, superimposed crescentic glomerulonephritis, and significant comorbidities faces a complex and concerning prognosis. Her disease trajectory is rapidly deteriorating, and multiple... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a 6-month history of progressive vision loss in both eyes. Initial examination revealed bilateral optic disc pallor and a constricted visual field. Genetic testing confirmed a homozygous mutation in the *OPA1* gene, consistent with Autosomal Dominant Optic A... | ADOA severity: homozygous *OPA1* mutation, early onset.
Family history: strong, early-onset blindness in grandfather.
Visual acuity: significantly reduced, bilateral, progressive.
RNFL thinning: disproportionate to field loss, rapid degeneration.
Age of onset: younger age predicts faster progression.
Comorbidity: asthm... | # Prognostic Assessment for Autosomal Dominant Optic Atrophy (ADOA)
This 9-year-old female with *OPA1*-related ADOA presents a challenging prognostic case due to several high-risk factors. Her homozygous mutation, early onset, and rapid RNFL thinning indicate an aggressive disease course.
**Short-Term Prognosis (Days... | prognostic |
A 9-year-old female, Maya, presents with a confirmed diagnosis of severe mitral stenosis secondary to rheumatic heart disease. She was diagnosed 18 months ago following recurrent episodes of pneumonia. Echocardiogram reveals a mitral valve area (MVA) of 0.7 cm², mean gradient of 15 mmHg at rest, and pulmonary artery sy... | Severe mitral stenosis indicates high hemodynamic stress.
Rheumatic etiology suggests ongoing inflammation risk.
Atrial fibrillation increases thromboembolic risk.
Elevated BNP reflects significant heart failure.
Low weight/height suggest nutritional compromise.
Limited access impacts timely intervention.
PASP 65mmHg i... | # Prognostic Assessment for Maya – Severe Mitral Stenosis
**Short-Term Prognosis (Days to Weeks):**
Maya is at moderate risk for decompensated heart failure exacerbation requiring hospitalization. The elevated BNP and NYHA Class III symptoms suggest she is close to this threshold. Risk of stroke is elevated due to atr... | prognostic |
Mr. Hiroshi Tanaka is a 93-year-old Japanese-American male presenting with worsening symptoms of late-onset (age 88) atypical depression, complicated by vascular dementia (diagnosed 2 years ago via MMSE = 18, CDR = 2). He lives alone, refusing assisted living despite increasing difficulty with activities of daily livin... | Advanced age significantly increases mortality risk.
Atypical depression complicates dementia prognosis.
Vascular dementia implies progressive cognitive decline.
APOE4/4 genotype: increased Alzheimer’s risk, faster decline.
High LDL cholesterol: vascular risk, cognitive worsening.
Functional decline: predicts increased... | # Prognostic Assessment for Mr. Hiroshi Tanaka
**Short-Term Prognosis (Days to Weeks):**
Mr. Tanaka is at moderate risk of functional decline and hospitalization within the next few weeks. The primary concern is worsening apathy and potential for increased falls due to his left-sided weakness and urinary incontinence.... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting with a locally advanced squamous cell carcinoma (SCC) of the oral tongue (T4N2cM0, Stage IVa) diagnosed three weeks ago via incisional biopsy and subsequent imaging. He initially presented with a painless ulcer on the lateral tongue, noticed inciden... | Advanced stage SCC significantly impacts overall survival.
Smoking/alcohol history worsen prognosis substantially.
Comorbidities (CKD, diabetes) increase treatment risks.
ECOG 1 suggests moderate functional reserve.
Cognitive impairment limits treatment adherence potential.
Age 82 increases risk of treatment toxicity.
... | # Prognostic Assessment for Mr. Hiroshi Tanaka
**Short-Term Prognosis (Days to Weeks):**
Mr. Tanaka faces a moderate risk of complications related to initiating treatment, particularly definitive chemoradiation. His CKD stage 3a increases the risk of renal toxicity from cisplatin. He is at risk for mucositis, dysphagi... | prognostic |
An 8-year-old female presents with a known diagnosis of Juvenile Nasopharyngeal Fibrosarcoma (JNF), Stage III, confirmed by biopsy and MRI. Initial diagnosis was 6 months ago. The tumor involves the right nasal cavity, extending into the maxillary sinus and partially obstructing the nasolacrimal duct. She has undergone... | Stage III JNF recurrence post-radiation indicates aggressive disease.
Positive margins initially suggest higher risk of local failure.
Recurrence within 6 months is concerning for rapid progression.
Asthma, well-controlled, minimal impact on prognosis directly.
Mild developmental delay impacts treatment adherence poten... | # Prognostic Assessment: Juvenile Nasopharyngeal Fibrosarcoma Recurrence
This 8-year-old female with recurrent Stage III JNF faces a challenging prognosis. The recurrence after radiation, coupled with positive initial margins and a relatively short time to recurrence (6 months), indicates a more aggressive disease cou... | prognostic |
A 28-year-old Hispanic male with a confirmed diagnosis of Crohn’s Disease (ileocolonic, L3-B2, Montreal classification) presents for follow-up. Diagnosis was made 3 years ago after colonoscopy and pathology revealed transmural inflammation and non-caseating granulomas. He initially responded well to induction therapy w... | Young age at diagnosis suggests aggressive disease course.
Ileocolonic location linked to higher complication rates.
Loss of response to two biologics is concerning.
Persistent inflammation despite adequate drug levels.
Smoking significantly worsens Crohn’s disease prognosis.
Low albumin indicates chronic inflammation/... | # Prognostic Assessment for Crohn’s Disease
This 28-year-old male with Crohn’s Disease presents a complex case requiring careful prognostic assessment. His disease course is concerning due to early age of onset, extensive disease location, and loss of response to multiple biologics. Several factors contribute to a gua... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a confirmed diagnosis of Legg-Calvé-Perthes Disease (LCPD) affecting her left hip. Initial presentation was 6 months ago with a subtle limp and mild left groin pain, initially dismissed as growing pains. Radiographs revealed early avascular necrosis of the f... | LCPD Stulberg II: moderate severity, variable outcomes.
Age 9: closer to skeletal maturity, worse prognosis.
Female gender: slightly increased risk of complications.
Ashkenazi Jewish ancestry: *GDF5* variant, OA risk.
High activity level: potential for accelerated degeneration.
Asthma: potential impact on rehabilitatio... | # Prognostic Assessment for Legg-Calvé-Perthes Disease (LCPD)
This 9-year-old female with Stulberg II LCPD presents a complex prognostic challenge due to multiple interacting risk factors. Her Ashkenazi Jewish ancestry and *GDF5* variant significantly elevate her risk for long-term hip dysplasia and osteoarthritis. He... | prognostic |
A 28-year-old male with a history of Cystic Fibrosis (CF) presents to the Emergency Department with acute exacerbation of respiratory symptoms. He was diagnosed with CF at age 2, genotype DF508 homozygous. He reports worsening dyspnea, productive cough with thick, purulent sputum, and fatigue over the past week. He den... | CF exacerbation: severity assessed by clinical & lab findings.
Multidrug-resistant *Pseudomonas* significantly worsens prognosis.
FEV1 55% indicates advanced lung disease severity.
CFRD complicates recovery and increases infection risk.
Liver disease adds to overall physiological burden.
Poor medication adherence impac... | # Prognostic Assessment for 28-Year-Old Male with Cystic Fibrosis Exacerbation
This patient presents a complex case with multiple interacting factors impacting prognosis. His CF exacerbation is complicated by multidrug-resistant *Pseudomonas aeruginosa* infection, advanced lung disease, comorbidities, and psychosocial... | prognostic |
Ethan, an 8-year-old African American male, presents with a confirmed diagnosis of Severe Conduct Disorder (SCD) with callous-unemotional traits, established 18 months ago. He exhibits persistent aggression towards peers and animals, property destruction, and deceitfulness. His mother reports escalating behavioral prob... | Severe Conduct Disorder, early onset, high PCL-YV score.
Callous-unemotional traits indicate poorer treatment response.
Family history of psychopathology increases risk significantly.
ADHD comorbidity complicates treatment and prognosis.
Exposure to violence worsens behavioral outcomes.
Poor academic performance signal... | # Prognostic Assessment for Ethan
**Short-Term Prognosis (Days to Weeks):**
Ethan is at high risk for continued aggressive outbursts, escalating behavioral problems at school, and potential involvement with the juvenile justice system. Without immediate intervention, the likelihood of further harm to animals or peers ... | prognostic |
A 52-year-old Hispanic female with a 12-year history of Type 2 Diabetes Mellitus (HbA1c consistently 8.5-9.5%) and a 7-year history of Hypertension (poorly controlled, average BP 150/90 mmHg) presents with progressive lower extremity edema and fatigue over the past 6 months. She was diagnosed with IgA Nephropathy 3 yea... | IgA nephropathy progression to crescentic disease severe.
Diabetes and hypertension accelerate kidney damage.
Poor glycemic control worsens nephropathy outcomes.
Non-adherence impacts treatment effectiveness significantly.
Reduced eGFR indicates advanced kidney dysfunction.
High proteinuria signifies ongoing glomerular... | # Prognostic Assessment for IgA Nephropathy with Crescentic Disease
This 52-year-old female with IgA nephropathy, now exhibiting crescentic glomerulonephritis, faces a guarded prognosis due to multiple interacting factors. Her underlying diabetes and hypertension, coupled with poor adherence and unfavorable biopsy fin... | prognostic |
A 28-year-old male presents with a confirmed diagnosis of Stage IIIC, Grade 3, serous ovarian cancer, initially misdiagnosed as testicular torsion due to a large, palpable mass. He is genetically 46,XY with complete androgen insensitivity syndrome (AIS), presenting as a phenotypic female. He underwent exploratory lapar... | Stage IIIC indicates advanced, widespread disease.
Grade 3 signifies aggressive tumor biology.
BRCA1 mutation predicts platinum sensitivity initially.
AIS complicates hormonal therapy considerations.
Diabetes impairs wound healing, increases infection risk.
Obesity impacts surgical outcomes, chemotherapy toxicity.
CKD ... | # Prognostic Assessment: Male with Ovarian Cancer & AIS
This case presents a complex prognostic challenge due to the unusual presentation of ovarian cancer in a genetic male with AIS, coupled with significant comorbidities and a poor initial response to chemotherapy. Prognosis is significantly worse than typical ovari... | prognostic |
Mr. David Chen, a 52-year-old Vietnamese-American male, presents to the ED with worsening shortness of breath and productive cough. He was diagnosed with Idiopathic Pulmonary Fibrosis (IPF) 3 years ago, confirmed by HRCT and lung biopsy. His disease has progressed despite treatment with pirfenidone. He reports a 6-mont... | IPF severity: advanced, declining 6MWD, extensive HRCT changes.
CAD history: increases risk of cardiac events, limits exercise.
Diabetes: impairs wound healing, increases infection risk.
Psychosocial factors: isolation, anxiety worsen outcomes.
DLCO 35%: indicates severe lung function impairment.
BNP elevation: suggest... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of advanced IPF with significant comorbidities and psychosocial challenges, requiring a nuanced prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at high risk for acute exacerbation of IPF (AE-IPF), a life-threateni... | prognostic |
A 52-year-old female, a former smoker (20 pack-year history, quit 10 years ago), presents with worsening dyspnea on exertion and a chronic cough productive of mucoid sputum. She was diagnosed with Idiopathic Pulmonary Fibrosis (IPF) 3 years ago based on HRCT findings (usual interstitial pneumonia pattern) and lung biop... | IPF severity: moderate-to-severe, declining FVC and DLCO.
Smoking history: past smoking increases exacerbation risk.
Acute exacerbations: prior exacerbations predict future events.
Comorbidities: diabetes and hypertension impact overall health.
Weight loss: significant weight loss indicates disease progression.
Desatur... | # Prognostic Assessment for Idiopathic Pulmonary Fibrosis
This 52-year-old female with IPF presents a complex case with multiple high-risk features, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Her current clinical status suggests a moderate risk of acute exacerbation. Giv... | prognostic |
A 6-month-old male infant of Northern European descent presents with a history of severe, refractory food protein-induced enterocolitis syndrome (FPIES) triggered by rice and oat. Initial presentation at 3 months involved profuse vomiting, lethargy, and pallor 1-4 hours post-ingestion, requiring multiple ED visits and ... | FPIES severity: recurrent, requiring ED visits, ICU admission.
Multiple triggers: rice and oat increase reaction probability.
Slow weight gain: nutritional compromise impacts development.
FLG mutation: eczema severity, barrier dysfunction increased.
Family history: atopy suggests broader allergic predisposition.
Comorb... | # Prognostic Assessment: Severe Refractory FPIES in Infancy
This 6-month-old infant with severe, multi-trigger FPIES presents a complex prognostic challenge. His case is complicated by comorbid atopic dermatitis, a *FLG* mutation, psychosocial stress, and limited access to care.
**Short-Term Prognosis (Days to Weeks)... | prognostic |
Mr. David Miller is a 52-year-old male presenting for prognostic assessment following a diagnosis of Stage II (T3N1M0) melanoma of the left lower leg, confirmed by excisional biopsy and sentinel lymph node biopsy 6 months ago. The melanoma was 2.1mm Breslow thickness, with ulceration and a mitotic rate of 8/mm. Sentine... | Stage II melanoma with lymph node involvement: high risk.
Breslow thickness, ulceration, mitotic rate: adverse features.
Positive lymph node, extracapsular extension: increased recurrence.
Diabetes, smoking: impair wound healing, immune function.
ECOG 1: moderate functional capacity, impacts treatment.
Anxiety, social ... | # Prognostic Assessment for Mr. David Miller – Stage II Melanoma
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s immediate prognosis is relatively good, assuming no surgical complications (infection, wound dehiscence). The primary concern is managing his lymphedema with compression therapy and monitoring for si... | prognostic |
A 2.5-year-old female of African American descent presents with a known diagnosis of Focal Segmental Glomerulosclerosis (FSGS), confirmed by kidney biopsy 6 months prior. Initial presentation involved nephrotic syndrome with significant edema and hypoalbuminemia. She has been steroid-resistant, failing two courses of p... | FSGS severity: steroid-resistant, declining GFR, high proteinuria.
NPHS1 mutation: increases risk of rapid disease progression.
Recurrent peritonitis: complicates PD, accelerates renal damage.
Low albumin: contributes to edema, malnutrition, poor growth.
GFR 45 mL/min: indicates moderate chronic kidney disease (CKD).
A... | # Prognostic Assessment for FSGS in a 2.5-Year-Old Female
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded due to the high risk of further acute kidney injury (AKI) episodes related to recurrent peritonitis and ongoing nephrotic syndrome. Maintaining adequate fluid and electrolyte balance,... | prognostic |
10-month-old male, born at 32 weeks gestation (birth weight 1.8kg), presents with worsening respiratory distress. He was diagnosed with Bronchopulmonary Dysplasia (BPD) at 3 months, requiring ongoing oxygen support. He has a history of recurrent Respiratory Syncytial Virus (RSV) infections, the most recent requiring ho... | Prematurity and BPD significantly increase respiratory morbidity.
Recurrent RSV infections worsen lung function, increasing risk.
PWS contributes to hypotonia, feeding difficulties, aspiration.
GERD exacerbates aspiration risk and respiratory symptoms.
Poor weight gain indicates nutritional compromise, impacting recove... | # Prognostic Assessment for 10-Month-Old Male with BPD, PWS, and Pneumonia
This 10-month-old infant presents a complex case with multiple interacting factors significantly impacting his prognosis. His prematurity, BPD, PWS, GERD, and recurrent respiratory infections create a challenging clinical picture.
**Short-Term... | prognostic |
A 28-year-old Hispanic male with a 7-year history of Crohn’s Disease, initially diagnosed with ileal involvement, presents with worsening symptoms despite maximal medical therapy. He was initially managed with mesalamine, then transitioned to azathioprine due to lack of response. Azathioprine was discontinued 18 months... | Extensive Crohn’s, multiple strictures, fistulas indicate severe disease.
Smoking significantly worsens Crohn’s disease course and complications.
Low albumin suggests malnutrition, impacting healing capacity.
NOD2 variant predicts more aggressive, treatment-refractory disease.
Prior azathioprine failure limits future t... | # Prognostic Assessment for Crohn’s Disease
This 28-year-old male with Crohn’s Disease presents a complex case with a concerning prognosis due to multiple high-risk factors. His disease is severe, refractory to multiple therapies, and complicated by fistulizing and stricturing behavior.
**Short-Term Prognosis (Days ... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents with end-stage renal disease (ESRD) secondary to focal segmental glomerulosclerosis (FSGS), initially diagnosed at age 22 following a post-streptococcal glomerulonephritis episode. She has been on hemodialysis for the past 18 months. Her FSGS is considered resistant to im... | ESRD severity: advanced, dialysis-dependent, FSGS resistant to therapy.
Diabetes: poorly controlled, multi-organ involvement, accelerates decline.
Recent infection: bacteremia increases cardiovascular risk significantly.
Nutritional status: moderate malnutrition, impacts recovery and survival.
Mineral bone disorder: se... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of ESRD with multiple interacting comorbidities that significantly impact her prognosis. Her young age is a relative positive, but is overshadowed by the severity and complexity of her condition.
**Short-Term Prognosis (Days to Weeks):**
H... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a 12-year history of Parkinson’s Disease (PD), initially presenting with tremor-dominant symptoms. He was diagnosed using UK Brain Bank criteria. Over the past 5 years, he has experienced increasing motor fluctuations despite optimized pharmacological management (Levodo... | Advanced PD, significant motor complications, impacts function.
Cognitive decline (PDD) accelerates disease progression.
Frequent falls indicate increased morbidity/mortality risk.
Depression and anxiety worsen outcomes, reduce adherence.
Living alone, limited social support, increases vulnerability.
Mild CKD complicat... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Established Diagnosis:** Parkinson’s Disease with Dementia (PDD), Stage 3-4 Hoehn & Yahr scale.
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at high risk for falls and related injuries in the immediate future. His fluctuating motor control and cogniti... | prognostic |
A 28-year-old male presents with known hypertrophic cardiomyopathy (HCM), diagnosed at age 16 following a family history of sudden cardiac death (SCD). He is asymptomatic at rest but experiences exertional dyspnea (NYHA Class II) and occasional palpitations with moderate activity. His ECG shows left ventricular hypertr... | HCM severity: Moderate obstruction, significant LV hypertrophy present.
PAF history increases stroke and heart failure risk.
Myocardial fibrosis indicates increased arrhythmia vulnerability.
Family history of SCD is a major risk indicator.
Smoking worsens cardiovascular health and prognosis.
Poor CPAP adherence exacerb... | # Prognostic Assessment for Hypertrophic Cardiomyopathy
This 28-year-old male with HCM presents a complex prognostic challenge due to multiple interacting risk factors. His case is considered high-risk, necessitating careful monitoring and potential intervention.
**Short-Term Prognosis (Days to Weeks):**
Relatively l... | prognostic |
Mrs. Evelyn Reed is an 82-year-old Caucasian female with a history of Stage IIIC serous ovarian cancer diagnosed 18 months ago. She initially underwent neoadjuvant chemotherapy (paclitaxel and carboplatin) followed by interval debulking surgery and adjuvant maintenance therapy with olaparib for 12 months. Her BRCA1 mut... | Ovarian cancer recurrence after platinum-based therapy.
BRCA mutation suggests potential PARP inhibitor sensitivity.
CKD stage 3 limits chemotherapy options and toxicity.
ECOG 1 indicates relatively good functional status.
Age 82 increases risk of treatment-related morbidity.
Recurrent CA-125 stable, suggesting slow pr... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):**
Mrs. Reed’s short-term prognosis is relatively stable, assuming adequate pain control and avoidance of acute complications. The stable CA-125 suggests the current disease state is not rapidly progressing. However, she remains at ris... | prognostic |
A 6-month-old male infant, born at 32 weeks gestation (birth weight 1.8kg), presents with worsening respiratory distress. He was diagnosed with Bronchopulmonary Dysplasia (BPD) at 4 weeks of age following premature birth and subsequent mechanical ventilation for Respiratory Distress Syndrome. He has been chronically ox... | Prematurity and BPD indicate significant lung immaturity.
RSV infection exacerbates underlying lung disease severity.
Chronic oxygen dependence signifies severe respiratory compromise.
Failure to thrive impacts overall physiological reserve.
GERD contributes to aspiration risk and inflammation.
Pulmonary hypertension w... | # Prognostic Assessment for Infant with Severe BPD
This 6-month-old infant with severe BPD faces a complex prognosis significantly impacted by multiple factors. The combination of prematurity, chronic respiratory distress, RSV infection, failure to thrive, GERD, and pulmonary hypertension creates a high-risk scenario.... | prognostic |
Mrs. Evelyn Reed is a 72-year-old African American female admitted to the ICU following a witnessed out-of-hospital cardiac arrest (OHCA) secondary to pulselmonary embolism (PE). She was resuscitated after 8 minutes of CPR with return of spontaneous circulation (ROSC). Initial ECG showed STEMI, and she underwent emerge... | OHCA etiology: PE, complicating cardiac arrest recovery.
Prolonged CPR impacts neurological outcome potential.
STEMI post-ROSC indicates significant myocardial injury.
CKD stage 3 increases infection and mortality risk.
Diabetes impairs healing and increases complications.
Factor V Leiden: recurrent thromboembolic risk... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):**
Mrs. Reed’s short-term prognosis is guarded. The immediate risk of mortality is high (estimated 30-50%) due to post-cardiac arrest syndrome, acute myocardial infarction, and ongoing acute kidney injury. Neurological prognosis is unc... | prognostic |
A 9-year-old female, of Navajo ethnicity, presents 72 hours post-ingestion of a significant amount of lead-based paint chips from her home (estimated 10-15g). She initially presented with abdominal pain, vomiting, and lethargy. Initial blood lead level (BLL) was 85 mcg/dL. She was treated with chelation therapy (Calciu... | High initial BLL indicates significant lead exposure.
Developmental regression signals neurotoxicity severity.
Persistent anemia complicates recovery process.
Navajo ethnicity: genetic predisposition to lead effects.
Poor housing, compliance: continued exposure risk.
Psychosocial stress impacts treatment adherence.
Che... | # Prognostic Assessment: Lead Neurotoxicity in a 9-Year-Old Female
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded. While chelation therapy has reduced the BLL, it remains elevated at 38 mcg/dL, indicating ongoing lead burden. The persistent developmental regression and neurological defic... | prognostic |
Mr. David Miller is a 48-year-old male with a 15-year history of severe, uncontrolled asthma, initially diagnosed at age 33. He has experienced frequent exacerbations requiring emergency department visits (average 3 per year) and multiple courses of oral corticosteroids. He was diagnosed with allergic bronchopulmonary ... | Severe asthma, long duration, poor control, high risk.
ABPA complicates asthma, accelerates lung damage progression.
Smoking significantly worsens respiratory function decline.
Occupational exposure exacerbates airway inflammation.
Pulmonary hypertension indicates advanced disease severity.
Obesity contributes to asthm... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case of severe asthma complicated by ABPA, significant comorbidities, and ongoing risk factors, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at high risk for acute asthma exacerbations... | prognostic |
A 28-year-old Hispanic male with a 5-year history of Crohn’s Disease, initially diagnosed with ileal involvement (L1), presents with worsening symptoms despite being on maintenance infliximab 5mg/kg every 8 weeks. He reports increased abdominal pain (VAS 7/10), nocturnal diarrhea (6-8 times daily), and new-onset perian... | Crohn’s disease severity: moderate-severe, expanding disease location.
Fistulizing disease indicates increased disease aggressiveness.
Recurrent CDI worsens prognosis, impacts treatment options.
Smoking significantly increases disease activity and complications.
Family history suggests increased CRC risk, requiring sur... | # Prognostic Assessment for Crohn’s Disease
This 28-year-old male with Crohn’s Disease presents a complex case with multiple factors influencing his prognosis. His disease is progressing despite anti-TNF therapy, complicated by recurrent *C. difficile* infection, and impacted by lifestyle and genetic factors.
**Short... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents with a confirmed diagnosis of Hypertrophic Cardiomyopathy (HCM), specifically apical HCM with significant left ventricular outflow tract (LVOT) obstruction. She was diagnosed 2 years ago after experiencing exertional dyspnea and palpitations. Initial echocardiogram showed... | HCM severity: Moderate obstruction, increasing wall thickness noted.
Family history: SCD risk significantly elevated, MYBPC3 mutation.
PVC burden: High PVCs increase arrhythmia and heart failure risk.
LGE extent: Extensive fibrosis indicates adverse remodeling potential.
Hypertension: Poorly controlled, exacerbates LV ... | # Prognostic Assessment for Ms. Anya Sharma – Hypertrophic Cardiomyopathy
**Short-Term Prognosis (Days to Weeks):**
Ms. Sharma is at low immediate risk of decompensation, *provided* her blood pressure remains managed and she avoids strenuous activity. However, the high PVC burden warrants close monitoring for potentia... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress and oliguria. He was diagnosed with Bilateral Renal Hypoplasia (BRH) via prenatal ultrasound, confirmed postnatally with renal ultrasound showing markedly reduced kidney size (right kidney 3cm, left ki... | Severe renal insufficiency present at birth.
Prematurity increases risk of complications.
BRH indicates limited renal regenerative capacity.
Maternal diabetes worsens renal development.
Down syndrome associated with increased morbidity.
*PAX2* mutation suggests progressive disease risk.
PPHN resolution impacts overall ... | # Prognostic Assessment for Bilateral Renal Hypoplasia in a Newborn
This case presents a complex scenario of a newborn with Bilateral Renal Hypoplasia (BRH), complicated by prematurity, maternal diabetes, Down syndrome, a *PAX2* gene mutation, and persistent pulmonary hypertension. Prognostic assessment requires consi... | prognostic |
Mr. David Chen, a 48-year-old Vietnamese-American male, presents for follow-up regarding his severe, uncontrolled asthma. He was diagnosed with severe eosinophilic asthma 10 years ago, initially well-controlled with inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA). Over the past 2 years, control has d... | Severe asthma, frequent exacerbations indicate poor control.
High eosinophil count suggests Th2-high inflammation.
OCS use indicates significant disease severity/refractoriness.
CRSwNP often co-exists, complicating asthma management.
Obesity and pre-diabetes worsen asthma outcomes.
Smoking history increases risk of COP... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of severe eosinophilic asthma with multiple interacting factors influencing his prognosis. His disease is characterized by significant morbidity, frequent exacerbations, and a poor response to conventional therapies. The presence of CRSwNP and... | prognostic |
Mrs. Eleanor Vance is a 93-year-old female admitted for worsening shortness of breath. She has a history of severe aortic stenosis (AS), diagnosed 5 years ago, previously managed conservatively due to age and frailty. Her echocardiogram 6 months ago showed an aortic valve area of 0.7 cm², mean gradient of 55 mmHg, and ... | Severe AS significantly limits cardiac output, impacting function.
Advanced age increases vulnerability to adverse events.
CKD stage 3a elevates cardiovascular risk and complications.
Atrial fibrillation increases stroke and heart failure risk.
Bedbound status indicates severe functional limitation, poor prognosis.
Wei... | # Prognostic Assessment for Mrs. Eleanor Vance
Mrs. Vance presents a complex case with multiple interacting comorbidities significantly impacting her prognosis. Her severe aortic stenosis, advanced age, and functional decline create a high-risk scenario.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognos... | prognostic |
Mr. David Miller is a 48-year-old male admitted to the ICU with severe pneumonia secondary to multi-drug resistant *Pseudomonas aeruginosa*. He has a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), chronic kidney disease stage 3 (eGFR 45 mL/min/1.73m²), and a 20-pack-year smoking history. He was ini... | Severe pneumonia, multi-drug resistance: high initial mortality.
Diabetes impairs immune function, worsens infection outcome.
CKD stage 3 increases susceptibility, complicates treatment.
Smoking history: chronic lung damage, reduced reserve.
Vasopressor requirement indicates significant hemodynamic instability.
High SO... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents with a complex case of severe, multi-drug resistant pneumonia complicated by significant comorbidities and psychosocial factors. His prognosis is guarded, with substantial risks in the short, medium, and long term.
**Short-Term Prognosis (Days to Weeks)... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting with a known diagnosis of Stage IIIC high-grade serous ovarian cancer (HGSOC) initially diagnosed 18 months ago. He was initially misdiagnosed with benign pelvic mass and presented late with significant abdominal distension and ascites. He underwent neoadjuvant che... | Advanced stage recurrence indicates aggressive disease biology.
Peritoneal carcinomatosis worsens prognosis significantly.
Prior platinum-based therapy limits re-treatment options.
CKD impacts chemotherapy tolerance and recovery.
ECOG 2 suggests reduced functional reserve.
Diabetes and hypertension increase complicatio... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents with a challenging case of recurrent HGSOC with multiple factors impacting prognosis. His late diagnosis, advanced stage at initial presentation, and now widespread peritoneal carcinomatosis indicate a particularly aggressive disease course.
**... | prognostic |
A 28-year-old African American female presents with known Takayasu Arteritis (TA) diagnosed 3 years prior based on clinical, laboratory, and imaging findings (PET/CT demonstrating aortic inflammation and stenosis). She initially responded well to glucocorticoids and methotrexate, but experienced multiple flares with st... | Young age, female gender: generally better TA prognosis.
Significant aortic stenosis: indicates advanced disease severity.
Multiple flares, steroid dependence: poor disease control.
Renal insufficiency: suggests vascular compromise, worsens outcome.
Claudication, dyspnea: functional limitations, impact quality of life.... | # Prognostic Assessment for Takayasu Arteritis
This 28-year-old female with Takayasu Arteritis presents a complex prognostic challenge due to multiple interacting factors. Her relatively young age and female gender are generally associated with a more favorable prognosis compared to older males. However, the presence ... | prognostic |
Mr. David Miller is a 52-year-old male presenting for prognostic assessment following a recent diagnosis of Stage IV (T3N2M1) non-small cell lung cancer (NSCLC) with adenocarcinoma histology. He was diagnosed after presenting with worsening cough, shortness of breath, and right shoulder pain. Imaging revealed a 6cm pri... | Stage IV NSCLC indicates inherently poor prognosis.
EGFR mutation suggests sensitivity to targeted therapy.
PD-L1 65% indicates potential immunotherapy benefit.
Smoking history contributes to increased risk of recurrence.
Diabetes and CKD complicate treatment and recovery.
ECOG 1 suggests moderate functional reserve.
B... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is largely dependent on his response to Osimertinib and management of his symptoms. Assuming reasonable tolerance of Osimertinib, he is likely to experience symptom improvement (cough, pain) within ... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a 7-year history of seropositive Rheumatoid Arthritis (RA), currently treated with methotrexate 15mg weekly and prednisone 7.5mg daily. He presents with worsening shortness of breath and a productive cough for 3 days. He has a history of ischemic heart disease (post-MI ... | RA severity: moderate activity, long duration, systemic features.
Comorbidities: IHD, CKD, COPD significantly impact prognosis.
Pneumonia: age increases risk of complications, mortality.
CKD stage 3a: limits treatment options, increases risk.
Low albumin: indicates malnutrition, poor prognosis.
Social isolation: impact... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple interacting factors influencing his prognosis. His RA, complicated by significant comorbidities and acute pneumonia, necessitates a nuanced assessment.
**Short-Term Prognosis (Days to Weeks):**
His immediate prognos... | prognostic |
A 2.5-year-old female, Anya, of Ashkenazi Jewish descent, presents with a confirmed diagnosis of infantile-onset Spinal Muscular Atrophy Type 1 (SMA1) diagnosed via genetic testing revealing biallelic SMN1 deletions. She initially presented at 6 months with generalized hypotonia and feeding difficulties. She currently ... | SMA1 severity: profound weakness, respiratory failure, early onset.
Genetic factors: biallelic SMN1 deletion, limited SMN2 copies.
Respiratory compromise: tracheostomy, ventilation, recurrent infections.
Nutritional status: G-tube dependent, aspiration risk present.
Skeletal involvement: progressive scoliosis despite b... | # Prognostic Assessment for Anya – Infantile SMA1
**Short-Term Prognosis (Days to Weeks):**
Anya’s short-term prognosis is guarded. She remains at high risk for respiratory complications (pneumonia, respiratory failure requiring increased ventilator support) and aspiration pneumonia. Frequent hospitalizations are like... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting for orthopedic consultation following a fall at home. He has a known history of Parkinson’s Disease (Hoehn & Yahr Stage III), well-controlled Type 2 Diabetes Mellitus, and chronic kidney disease (Stage 3a, eGFR 48 ml/min/1.73m2). Radiographs reveal an intertrochant... | Intertrochanteric fracture, age 72, increases complication risk.
Parkinson’s Disease (Stage III) impacts recovery potential.
CKD Stage 3a impairs healing and increases surgical risk.
Diabetes, well-controlled, still elevates infection risk.
Cognitive impairment hinders rehabilitation adherence.
Low albumin suggests mal... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple comorbidities significantly impacting his prognosis following an intertrochanteric femur fracture. His age, pre-existing conditions, and functional status all contribute to a higher risk profile.
**Short-Term Progno... | prognostic |
A 2.5-year-old male of Ashkenazi Jewish descent presents with a history of recurrent lower respiratory tract infections since 6 months of age. He was diagnosed with Cystic Fibrosis (CF) at 1 year old following a positive newborn screen and sweat chloride testing (105 mmol/L). He has a F508del/W1282X genotype. He curren... | CF severity: moderate, based on PFTs and chronic infection.
F508del genotype: associated with poorer lung function.
Chronic *Pseudomonas* colonization: accelerates lung damage.
Pancreatic insufficiency: impacts nutrition and growth.
DIOS history: indicates significant gastrointestinal complications.
Failure to thrive: ... | # Prognostic Assessment for a 2.5-Year-Old with Cystic Fibrosis
This 2.5-year-old male with Cystic Fibrosis presents a complex case requiring careful prognostic assessment. His prognosis is significantly impacted by multiple interacting factors, making a precise prediction challenging.
**Short-Term Prognosis (Days to... | prognostic |
A 48-year-old African American female with a 15-year history of severe asthma, poorly controlled despite step-up therapy to omalizumab, presents with worsening dyspnea and cough productive of purulent sputum. She was diagnosed with Allergic Bronchopulmonary Aspergillosis (ABPA) 5 years ago, with recurrent exacerbations... | Severe asthma, ABPA, CRSwNP: complex, interacting conditions.
Frequent exacerbations indicate poor disease control, higher risk.
S. aureus colonization increases pneumonia risk, worsens outcomes.
CFTR heterozygosity: potential for airway dysfunction, infection.
Low FEV1 (55%) signifies significant lung impairment.
High... | # Prognostic Assessment for Allergic Bronchopulmonary Aspergillosis (ABPA) and Severe Asthma
This 48-year-old African American female presents a complex case with multiple interacting conditions significantly impacting her prognosis. Her established diagnoses of severe asthma, ABPA, and CRSwNP, coupled with recurrent ... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with newly diagnosed, Stage III High-Risk Medulloblastoma. The tumor is located in the posterior fossa and has demonstrated extensive cerebellar metastasis on MRI. Biopsy confirms the Large Cell subtype with MYC amplification. Pre-operative neurological exam reve... | Medulloblastoma stage III, high-risk, poor initial prognosis.
Large cell subtype and MYC amplification worsen outlook.
Cerebellar metastasis indicates aggressive disease spread.
Cranial nerve palsies suggest significant neurological impact.
Positive CSF cytology: leptomeningeal disease present.
BRCA2 heterozygosity: po... | # Prognostic Assessment: Stage III High-Risk Medulloblastoma
This 9-year-old patient with Stage III High-Risk Medulloblastoma faces a challenging prognosis due to multiple adverse factors. Her case is particularly complex given the combination of aggressive tumor biology, metastatic disease, and psychosocial stressors... | prognostic |
Mr. Elias Vance is a 72-year-old African American male presenting for evaluation of worsening fatigue and bone pain. He was diagnosed with Multiple Myeloma IgG-kappa, ISS Stage III, six months ago and completed six cycles of VRd (Bortezomib, Lenalidomide, Dexamethasone). He achieved a very good partial response (VGPR) ... | Myeloma relapse after initial VRd therapy identified.
ISS Stage III indicates aggressive disease course.
Del(17p) signifies high-risk genetic abnormality.
CKD stage 3a limits treatment options/tolerability.
Prior MI increases cardiovascular risk during therapy.
Low albumin suggests poor nutritional status.
Elevated LDH... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of relapsed Multiple Myeloma with multiple high-risk features, necessitating a cautious and nuanced prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Vance is at risk for skeletal events (pathological fracture, spinal cor... | prognostic |
A 9-year-old male of mixed African and European ancestry presents with a confirmed diagnosis of Severe Hemophilia A (Factor VIII deficiency <1%). He experienced a significant intracranial hemorrhage (ICH) six months prior, requiring prolonged ICU admission and resulting in residual left hemiparesis (modified Rankin Sca... | Severe hemophilia A indicates high bleeding risk.
Prior ICH signifies increased future hemorrhage risk.
Hemiparesis impacts functional independence, recovery.
Recurrent pneumonia suggests immune dysfunction.
Sickle trait complicates management, vaso-occlusion risk.
Poor adherence worsens bleeding, treatment efficacy.
N... | # Prognostic Assessment: Severe Hemophilia A with Comorbidities
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded, primarily due to the risk of further bleeding episodes, particularly given inconsistent adherence to prophylaxis and the presence of chronic microvascular disease. The risk of ... | prognostic |
A 2-week-old female infant, born at 30 weeks gestation (birth weight 1.2kg), initially presented with respiratory distress syndrome (RDS) requiring surfactant administration and mechanical ventilation. She was diagnosed with Bronchopulmonary Dysplasia (BPD) – Stage 3 (severe) at 4 weeks, complicated by patent ductus ar... | Prematurity significantly increases BPD risk and severity.
Severe BPD (Stage 3) indicates substantial lung damage.
Hemodynamically significant PDA worsens pulmonary perfusion.
CFTR heterozygosity may subtly impact lung function.
Maternal asthma suggests genetic predisposition to airway disease.
Psychosocial stress impa... | # Prognostic Assessment for Infant with Severe BPD
This 2-week-old female infant with severe BPD, complicated by PDA, CFTR heterozygosity, maternal asthma, psychosocial stress, growth failure, and PAH presents a complex prognostic challenge. Prognostic assessment must consider the interplay of these factors.
**Short... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male presenting with worsening fatigue, easy bruising, and recurrent epistaxis over the past 3 months. He was diagnosed 6 months ago with Chronic Lymphocytic Leukemia (CLL), Rai Stage II. Initial cytogenetic analysis revealed del(13q) as the sole abnormality. He has a history of ... | CLL stage II, progressing with del(17p) – unfavorable.
Del(17p) indicates TP53 mutation, aggressive disease course.
Elevated beta-2 microglobulin signifies increased tumor burden.
Rising LDH suggests increased cell turnover, poor prognosis.
Anemia and thrombocytopenia contribute to morbidity/mortality.
CKD impacts trea... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of CLL with several factors influencing his prognosis. His initial Rai Stage II diagnosis was relatively indolent, but the acquisition of del(17p) significantly alters his risk profile.
**Short-Term Prognosis (Days to Weeks):**
M... | prognostic |
Mr. David Miller is a 52-year-old male presenting with worsening fatigue, night sweats, and unintentional weight loss (15 lbs over 3 months). He was diagnosed 6 months ago with Chronic Lymphocytic Leukemia (CLL), Rai Stage III, with del(17p) identified via FISH testing. His absolute lymphocyte count is currently 85,000... | CLL stage III with del(17p): high-risk disease.
Rapidly rising lymphocyte count indicates aggressive progression.
Splenomegaly contributes to cytopenias and discomfort.
Del(17p) predicts resistance to fludarabine-based therapy.
Elevated beta-2 microglobulin signifies advanced disease burden.
LDH elevation suggests incr... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case of CLL with multiple high-risk features, necessitating a detailed prognostic assessment. His prognosis is significantly guarded due to the aggressive nature of his disease and the presence of several adverse factors.
**Short-Term Prognosi... | prognostic |
A 16-year-old female of Nigerian descent presents with worsening symptoms of HIV-associated neurocognitive syndrome (HAND). She was diagnosed with HIV perinatally (mother’s infection unknown) and initially lost to follow-up until age 14, when she presented with a CD4 count of 80 cells/µL and a viral load of 550,000 cop... | Perinatal HIV, late ART initiation: severe disease risk.
Low nadir CD4 count: increased neurocognitive impairment risk.
HAND diagnosis: indicates established neurological damage.
Recurrent PJP: suggests immune reconstitution challenges.
LTBI: potential for active TB impacting neurological status.
Psychosocial stressors... | # Prognostic Assessment for HIV-Associated Neurocognitive Syndrome (HAND)
This 16-year-old female with a complex medical and psychosocial history presents a significant challenge for prognostic assessment. Her perinatal HIV infection, delayed ART initiation, and history of opportunistic infections contribute to a guar... | prognostic |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.